Intervention, Nuclear Medicine and Immunotherapy for Anti-tumor

TLX101

Radionuclide-drug Conjugate (RDC), Orphan Drug Designation granted by the FDA
  • Drug Name: 131I-IPA
  • Trade Name: TLX101
  • Indication: Glioblastoma